Abstract
IntroductionOral anticoagulation (OAC) has long been the standard of care for stroke prevention for patients with non-valvular atrial fibrillation (AF). Left atrial appendage closure (LAAC) has emerged in recent years...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
